Canaccord conducts a sensitivity analysis of the Israeli pharmaceutical firm InterCure's (INCR) estimated share price in figure 33 on page 30:
Estimate the Macaulay duration of INCR's equity. The Macaulay duration is approximately:
An analyst has prepared a discounted cash flow model to value a firm's share price. A sensitivity analysis data table with ‘conditional formatting’ shading is shown below. The table shows how changes in the weighted average cost of capital (WACC, left column) and terminal value growth rate (top row) affect the firm's model-estimated share price.
The base case estimates are shown in bold.
Which of the following statements is NOT correct? The model-estimated share price would normally be expected to: